Combination products like multi-drug pills, inhalers, and topical creams face unique bioequivalence challenges that delay generic access. Learn why testing them is harder, costlier, and more complex than single-drug generics.
Details
Bioavailability studies ensure generic drugs work like brand-name versions by measuring how much and how fast the active ingredient enters the bloodstream. The FDA uses AUC and Cmax data to confirm equivalence within an 80-125% range.
Details
Learn the real differences between generic rosuvastatin and brand-name Crestor, covering efficacy, safety, price, and when each option is best for you.
Details